News & Analysis

Investors maintain healthy appetite for life sciences

Institutional investment in life sciences real estate is set to grow in both the US and UK markets, says James Jacobs, head of real estate for Lazard’s private capital advisory group.

By

Guest Writer

28 June 2023•2 mins read

Related articles

alt

NBIM encourages Prologis, Segro to pursue takeover talks as deadline nears

21 July 2026 · 2 mins read

alt

EQT puts US multifamily back on the radar

21 July 2026 · 3 mins read

alt

AEW appoints European investor relations lead

21 July 2026 · 2 mins read

alt

Hines promotes APAC and Middle East head in regional restructuring

21 July 2026 · 3 mins read

alt

Townsend raises $2bn for real estate secondaries

20 July 2026 · 3 mins read

alt

Private real estate fund managers go harder on fee discounts

20 July 2026 · 5 mins read

alt

Prologis CIO joins Tishman Speyer to lead global expansion

16 July 2026 · 3 mins read

motif